Parallel Advisors, LLC Verastem, Inc. Transaction History

Parallel Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 27, 2020	SELL	$1.26 - $3.38 $13,860 - $37,180	-11,000 Reduced 64.71%	6,000 $15,000
Q4 2019 Jan 30, 2020	SELL	$0.86 - $1.44 $4,300 - $7,200	-5,000 Reduced 22.73%	17,000 $23,000
Q2 2019 Aug 05, 2019	SELL	$1.25 - $3.14 $1,250 - $3,140	-1,000 Reduced 4.35%	22,000 $33,000
Q1 2019 May 01, 2019	SELL	$2.79 - $4.09 $2,790 - $4,090	-1,000 Reduced 4.17%	23,000 $68,000
Q4 2018 Feb 05, 2019	BUY	$3.23 - $7.01 $35,530 - $77,110	11,000 Added 84.62%	24,000 $80,000
Q3 2018 Nov 01, 2018	BUY	$6.86 - $9.97 $58,310 - $84,745	8,500 Added 188.89%	13,000 $94,000
Q2 2018 Jul 30, 2018	BUY	$2.88 - $8.67 $12,960 - $39,015	4,500 New	4,500 $30,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.2B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.